Best Paper Award 2026: nominations now open
Nominations for the 2026 Best Paper Award are open until 30 September. Any research article published in the journal during 2026 i…
More →
This is a peer-reviewed, open-access journal dedicated to the genomic and epigenomic drivers of cancer. We publish original research, methodological advances and critical reviews spanning…
Journal Manager Demo 3 — Peer-reviewed, open access, and free to read and to publish in — a demonstration journal built on JournalManager. We publish original research on the genomic and epigenomic basis of cancer, alongside the computational methods that make that research possible. The journal is edited by working…
More →Genomics of Carcinogenesis
This issue gathers work on the genomic and epigenomic drivers of carcinogenesis, from the mechanisms that let a cell escape its constraints to the computational methods that let us watch them do it. Original research sits alongside methodological papers, and every article is free to read from the day it appears.
The issue is organised around three threads. Discovery covers tumour evolution, epigenetic regulation and structural variation, including single-cell and spatial approaches to heterogeneity. Translation takes in biomarkers, liquid biopsy and mechanisms of acquired treatment resistance. Methods covers benchmarking studies and analytical tooling released with documented, runnable code.
All articles are published under a Creative Commons licence with no article processing charges. Data and code are deposited as a condition of acceptance, so every figure in this issue can be reproduced from its source.
Publish Date: 2026-06-13
Current Issue →Nominations for the 2026 Best Paper Award are open until 30 September. Any research article published in the journal during 2026 i…
More →We invite submissions for a themed collection on single-cell approaches to tumour evolution. Contributions addressing lineage trac…
More →Following changes to our editorial workflow, median time from submission to first decision has fallen to 18 days, down from 34 day…
More →The journal now accepts Registered Reports, in which study protocols are peer reviewed before data collection begins. Accepted pro…
More →A special issue on cancer epigenetics will be guest edited by Dr Ingrid Moreau. Topics include DNA methylation biomarkers, chromat…
More →Our forthcoming special issue focuses on liquid biopsy technologies for early cancer detection, covering assay development, clinic…
More →The journal has been accepted for indexing in Scopus and PubMed Central. All content published from volume 1 onwards will be retro…
More →From 1 August 2026, all articles reporting primary genomic data must deposit raw sequence data in a recognised public repository a…
More →We are expanding our reviewer pool in cancer genomics, computational biology and clinical oncology. Reviewers receive formal recog…
More →We welcome twelve new members to the editorial board for 2026, bringing expertise in single-cell genomics, epigenetics, immuno-onc…
More →